Article Menu
- Subscribe SciFeed
- Recommended Articles
- Related Info Links
-
More by Authors Links
- on DOAJ
- Vergori, A.
- Matusali, G.
- Cimini, E.
- Bordi, L.
- Borrelli, P.
- Lanini, S.
- Palazzi, R.
- Paulicelli, J.
- Mariotti, D.
- Mazzotta, V.
- Notari, S.
- Casetti, R.
- Francalancia, M.
- Rosati, S.
- D’Abramo, A.
- Mija, C.
- Mencarini, P.
- Milozzi, E.
- Caraffa, E.
- Sica, S.
- Metafuni, E.
- Sorà , F.
- Rago, A.
- Siniscalchi, A.
- Abruzzese, E.
- Garzia, M.
- Luzi, G.
- Battistini, R.
- Prosperini, L.
- Cingolani, A.
- Girardi, E.
- Maggi, F.
- Antinori, A.
- on Google Scholar
- Vergori, A.
- Matusali, G.
- Cimini, E.
- Bordi, L.
- Borrelli, P.
- Lanini, S.
- Palazzi, R.
- Paulicelli, J.
- Mariotti, D.
- Mazzotta, V.
- Notari, S.
- Casetti, R.
- Francalancia, M.
- Rosati, S.
- D’Abramo, A.
- Mija, C.
- Mencarini, P.
- Milozzi, E.
- Caraffa, E.
- Sica, S.
- Metafuni, E.
- Sorà , F.
- Rago, A.
- Siniscalchi, A.
- Abruzzese, E.
- Garzia, M.
- Luzi, G.
- Battistini, R.
- Prosperini, L.
- Cingolani, A.
- Girardi, E.
- Maggi, F.
- Antinori, A.
- on PubMed
- Vergori, A.
- Matusali, G.
- Cimini, E.
- Bordi, L.
- Borrelli, P.
- Lanini, S.
- Palazzi, R.
- Paulicelli, J.
- Mariotti, D.
- Mazzotta, V.
- Notari, S.
- Casetti, R.
- Francalancia, M.
- Rosati, S.
- D’Abramo, A.
- Mija, C.
- Mencarini, P.
- Milozzi, E.
- Caraffa, E.
- Sica, S.
- Metafuni, E.
- Sorà , F.
- Rago, A.
- Siniscalchi, A.
- Abruzzese, E.
- Garzia, M.
- Luzi, G.
- Battistini, R.
- Prosperini, L.
- Cingolani, A.
- Girardi, E.
- Maggi, F.
- Antinori, A.
Need Help?
Order Article Reprints
Journal: Vaccines, 2024
Volume: 12
Number: 784
784
Article:
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Authors:
by
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, Licia Bordi, Paola Borrelli, Simone Lanini, Roberta Palazzi, Jessica Paulicelli, Davide Mariotti, Valentina Mazzotta, Stefania Notari, Rita Casetti, Massimo Francalancia, Silvia Rosati, Alessandra D’Abramo, Cosmina Mija, Paola Mencarini, Eugenia Milozzi, Emanuela Caraffa, Simona Sica, Elisabetta Metafuni, Federica Sorà , Angela Rago, Agostina Siniscalchi, Elisabetta Abruzzese, Mariagrazia Garzia, Giovanni Luzi, Roberta Battistini, Luca Prosperini, Antonella Cingolani, Enrico Girardi, Fabrizio Maggi and Andrea Antinoriadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2076-393X/12/7/784
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Vergori, A.; Matusali, G.; Cimini, E.; Bordi, L.; Borrelli, P.; Lanini, S.; Palazzi, R.; Paulicelli, J.; Mariotti, D.; Mazzotta, V.; et al. Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study. Vaccines 2024, 12, 784. https://doi.org/10.3390/vaccines12070784
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, Palazzi R, Paulicelli J, Mariotti D, Mazzotta V, et al. Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study. Vaccines. 2024; 12(7):784. https://doi.org/10.3390/vaccines12070784
Chicago/Turabian StyleVergori, Alessandra, Giulia Matusali, Eleonora Cimini, Licia Bordi, Paola Borrelli, Simone Lanini, Roberta Palazzi, Jessica Paulicelli, Davide Mariotti, Valentina Mazzotta, and et al. 2024. "Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study" Vaccines 12, no. 7: 784. https://doi.org/10.3390/vaccines12070784
APA StyleVergori, A., Matusali, G., Cimini, E., Bordi, L., Borrelli, P., Lanini, S., Palazzi, R., Paulicelli, J., Mariotti, D., Mazzotta, V., Notari, S., Casetti, R., Francalancia, M., Rosati, S., D’Abramo, A., Mija, C., Mencarini, P., Milozzi, E., Caraffa, E., ... Antinori, A., on behalf of the OCTOPUS Study Group. (2024). Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study. Vaccines, 12(7), 784. https://doi.org/10.3390/vaccines12070784
